Cargando…

The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial

INTRODUCTION: Obese breast cancer patients have worse prognosis than normal weight patients, but the level at which obesity is prognostically unfavorable is unclear. METHODS: This retrospective analysis was performed using data from the SUCCESS A trial, in which 3754 patients with high-risk early br...

Descripción completa

Detalles Bibliográficos
Autores principales:	Widschwendter, Peter, Friedl, Thomas WP, Schwentner, Lukas, DeGregorio, Nikolaus, Jaeger, Bernadette, Schramm, Amelie, Bekes, Inga, Deniz, Miriam, Lato, Krisztian, Weissenbacher, Tobias, Kost, Bernd, Andergassen, Ulrich, Jueckstock, Julia, Neugebauer, Julia, Trapp, Elisabeth, Fasching, Peter A., Beckmann, Matthias W., Schneeweiss, Andreas, Schrader, Ines, Rack, Brigitte, Janni, Wolfgang, Scholz, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575482/ https://www.ncbi.nlm.nih.gov/pubmed/26385214 http://dx.doi.org/10.1186/s13058-015-0639-3

Ejemplares similares

Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer – Results of the German SUCCESS-A- trial
por: Jueckstock, Julia, et al.
Publicado: (2016)

Estrogen Receptor and HER2 Status on Disseminated Tumor Cells and Primary Tumor in Patients with Early Breast Cancer
por: Jäger, Bernadette A.S., et al.
Publicado: (2015)

Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial
por: de Gregorio, Amelie, et al.
Publicado: (2020)

The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial
por: Jaeger, B. A. S., et al.
Publicado: (2017)

Evaluation of Two Different Analytical Methods for Circulating Tumor Cell Detection in Peripheral Blood of Patients with Primary Breast Cancer
por: Jaeger, B. A. S., et al.
Publicado: (2014)

Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients
por: Rack, Brigitte, et al.
Publicado: (2014)

Foetal Doppler Parameters as a Prognostic Marker Before Induction of Labour
por: Widschwendter, Peter, et al.
Publicado: (2018)

Evaluation of Sentinel Lymph Node Dose Distribution in 3D Conformal Radiotherapy Techniques in 67 pN0 Breast Cancer Patients
por: Witucki, Gerlo, et al.
Publicado: (2015)

Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients
por: Alunni-Fabbroni, Marianna, et al.
Publicado: (2018)

Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study
por: Janni, W, et al.
Publicado: (2016)

MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients
por: Huebner, Hanna, et al.
Publicado: (2022)

Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis—Results from the Adjuvant SUCCESS A Trial
por: Trapp, Elisabeth K., et al.
Publicado: (2022)

LKB1 pro‐oncogenic activity triggers cell survival in circulating tumor cells
por: Trapp, Elisabeth Katharina, et al.
Publicado: (2017)

Are Circulating Tumor Cells (CTCs) Ready for Clinical Use in Breast Cancer? An Overview of Completed and Ongoing Trials Using CTCs for Clinical Treatment Decisions
por: Schochter, Fabienne, et al.
Publicado: (2019)

Effect of an Augmented Reality Ultrasound Trainer App on the Motor Skills Needed for a Kidney Ultrasound: Prospective Trial
por: Ebner, Florian, et al.
Publicado: (2019)

Angiogenic cytokines and their influence on circulating tumour cells in sera of patients with the primary diagnosis of breast cancer before treatment
por: Vilsmaier, Theresa, et al.
Publicado: (2016)

Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
por: Polasik, Arkadius, et al.
Publicado: (2017)

The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer—a pooled analysis of the randomised clinical trials PlanB and SUCCESS C
por: de Gregorio, Amelie, et al.
Publicado: (2022)

Axillary Surgery in Breast Cancer Patients Treated with Breast-Conserving Surgery at German Breast Cancer Centers Within the Last 14 Years – Comparison of a University Center and a Community Hospital
por: de Gregorio, Amelie, et al.
Publicado: (2018)

Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC status
por: Vilsmaier, Theresa, et al.
Publicado: (2020)

Pathway-Based Analysis of Genome-Wide Association Data Identified SNPs in HMMR as Biomarker for Chemotherapy- Induced Neutropenia in Breast Cancer Patients
por: Bidadi, Behzad, et al.
Publicado: (2018)

Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer
por: Müller, Volkmar, et al.
Publicado: (2011)

To which extent do breast cancer survivors feel well informed about disease and treatment 5 years after diagnosis?
por: Herbert, S. L., et al.
Publicado: (2020)

The integrative epigenomic-transcriptomic landscape of ER positive breast cancer
por: Gao, Yang, et al.
Publicado: (2015)

Erratum to: The integrative epigenomic-transcriptomic landscape of ER positive breast cancer
por: Gao, Yang, et al.
Publicado: (2016)

CT Scan in the Prediction of Lymph Node Involvement in Ovarian Cancer – a Retrospective Analysis of a Tertiary Gyneco-Oncological Unit
por: Widschwendter, Peter, et al.
Publicado: (2020)

Novel and flexible ultrasound simulation with smartphones and tablets in fetal echocardiography
por: Hartmann, Tim Johannes, et al.
Publicado: (2021)

Rationale and description of a lifestyle intervention programme to achieve moderate weight loss in women with non-metastatic breast cancer: the lifestyle intervention part of the SUCCESS C Study
por: Hauner, Dagmar, et al.
Publicado: (2020)

Results of an internal audit on the survival of patients with uterine sarcoma
por: Ebner, Florian, et al.
Publicado: (2019)

Does VEGF facilitate local tumor growth and spread into the abdominal cavity by suppressing endothelial cell adhesion, thus increasing vascular peritoneal permeability followed by ascites production in ovarian cancer?
por: Bekes, Inga, et al.
Publicado: (2016)

Cardiac late effects after modern 3D-conformal radiotherapy in breast cancer patients: a retrospective cohort study in Germany (ESCaRa)
por: Merzenich, Hiltrud, et al.
Publicado: (2021)

DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer
por: Teschendorff, Andrew E, et al.
Publicado: (2016)

Role of Pelvic Lymph Node Resection in Vulvar Squamous Cell Cancer: A Subset Analysis of the AGO-CaRE-1 Study
por: Woelber, Linn, et al.
Publicado: (2021)

Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study
por: Müller, Volkmar, et al.
Publicado: (2012)

53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients
por: Schochter, Fabienne, et al.
Publicado: (2020)

Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program
por: Müller, V., et al.
Publicado: (2021)

Novel Method for Three-Dimensional Facial Expression Recognition Using Self-Normalizing Neural Networks and Mobile Devices
por: Hartmann, Tim Johannes, et al.
Publicado: (2022)

AGO Algorithms for the Treatment of Breast Cancer: Update 2021
por: Schneeweiss, Andreas, et al.
Publicado: (2021)

Clinical validation of genetic variants associated with in vitro chemotherapy-related lymphoblastoid cell toxicity
por: Fasching, Peter A., et al.
Publicado: (2017)

A Scary Complication: Single-center Study on Management and Outcome of Cesarean Scar Pregnancy
por: Hüner, Beate, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_546jl4gbmvbsk25u7i4ghg80p6